The Clorox Company $CLX Shares Purchased by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC raised its stake in The Clorox Company (NYSE:CLX) by 64.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 25,732 shares of the company’s stock after buying an additional 10,065 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Clorox were worth $3,173,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Nomura Asset Management Co. Ltd. boosted its position in shares of Clorox by 9.0% in the second quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock worth $40,285,000 after buying an additional 27,639 shares during the period. Simplicity Wealth LLC lifted its stake in Clorox by 157.3% in the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after acquiring an additional 11,198 shares in the last quarter. Hudson Bay Capital Management LP purchased a new stake in Clorox in the 2nd quarter worth about $8,568,000. Vise Technologies Inc. purchased a new position in Clorox during the 2nd quarter valued at about $328,000. Finally, Brookstone Capital Management grew its stake in Clorox by 1,395.4% during the 3rd quarter. Brookstone Capital Management now owns 94,332 shares of the company’s stock valued at $11,631,000 after acquiring an additional 88,024 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently issued reports on CLX. JPMorgan Chase & Co. reduced their price target on shares of Clorox from $120.00 to $114.00 and set a “neutral” rating for the company in a research report on Friday, January 16th. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Barclays reissued an “underweight” rating and set a $109.00 target price on shares of Clorox in a research note on Friday, January 16th. TD Cowen restated a “hold” rating on shares of Clorox in a report on Thursday, January 8th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a report on Friday, January 9th. One equities research analyst has rated the stock with a Buy rating, thirteen have assigned a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus price target of $122.19.

Insiders Place Their Bets

In related news, Director Pierre R. Breber bought 4,000 shares of the firm’s stock in a transaction on Friday, November 21st. The stock was purchased at an average price of $104.13 per share, with a total value of $416,520.00. Following the completion of the transaction, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox Stock Down 3.9%

Clorox stock opened at $108.83 on Thursday. The company has a current ratio of 0.76, a quick ratio of 0.50 and a debt-to-equity ratio of 18.01. The Clorox Company has a 1-year low of $96.66 and a 1-year high of $161.45. The firm’s fifty day simple moving average is $104.50 and its 200-day simple moving average is $114.46. The company has a market capitalization of $13.28 billion, a P/E ratio of 17.08, a P/E/G ratio of 0.56 and a beta of 0.58.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.41 billion. Clorox had a net margin of 11.68% and a return on equity of 358.39%. Clorox’s revenue for the quarter was down 18.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio (DPR) is presently 77.86%.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.